Forte Biosciences, Inc. (FBRX) Financials

FBRX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 205.7 million 21.9 million
March 31, 2026 67.2 million 25.1 million
Dec. 31, 2025 82.8 million 21.8 million
Sept. 30, 2025 97.1 million 13.0 million

FBRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 18.8 million -3.2 million
March 31, 2026 -18.8 million 3.2 million
Dec. 31, 2025 -16.5 million 1.7 million
Sept. 30, 2025 -14.1 million 1.5 million

FBRX Net Income

No data available :(

FBRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 198.5 million - -
March 31, 2026 58.2 million - -
Dec. 31, 2025 77.0 million - -
Sept. 30, 2025 93.4 million - -

FBRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 23.8 million
March 31, 2026 17.8 million
Dec. 31, 2025 17.9 million
Sept. 30, 2025 17.8 million

FBRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 150000 2.3 million -
March 31, 2026 - 20.3 million 2.0 million -
Dec. 31, 2025 - 21.4 million 2.8 million -
Sept. 30, 2025 55000 15.1 million 3.2 million -

FBRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 19000
Dec. 31, 2025 - -45000
Sept. 30, 2025 - 17000

FBRX

Price: $76.83

52 week price:
9.10
77.20

Earnings Per Share: -4.57 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 50864

Market Capitalization: 1.6 billion

Links: